Cybin Corp.
Private Company
Company Overview
Cybin Corp. is focused on furthering the research and development of psilocybin through its wholly-owned subsidiary, Serenity Life Sciences Inc., and developing proprietary medicinal mushroom products through its wholly-owned subsidiary, Natures Journey Inc.
The company's IP strategy revolves around psychedelic delivery mechanisms, synthetic compounds, extraction methods, isolation of chemical compounds, new drug formulations and protocol regiments. Its experienced management team has run multiple clinical trials and successfully brought many new drugs to market in the past.
The company's IP strategy revolves around psychedelic delivery mechanisms, synthetic compounds, extraction methods, isolation of chemical compounds, new drug formulations and protocol regiments. Its experienced management team has run multiple clinical trials and successfully brought many new drugs to market in the past.
Management Team
Paul Glavine
CEO
John Kanakis
Co-Founder & SVP Business Development
Eric So
Co-Founder & President
Lori Challenger
Regulatory Compliance